A clinical trial to study role of vaitaran basti in middle age amavaat patients with elevated C-Reactive Protein

Role of vaitaran basti on elevated C-Reactive protein in middle age Amavata Patients w.s.r. Rheumatoid Arthritis-A pilot study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084071

Enrollment

Registered

2025-04-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M064- Inflammatory polyarthropathy

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient having classical signs and symptoms of Amavata like Sandhishoola,Sandhu stabdhta,Sandhi Shoth Patient have confirmed the diagnosis by using RF and CRP test Patient having raised CRP level Are selected for the study

Exclusion criteria

Exclusion criteria: Patient age below 30 years and above 50 years Patient with diabetes and cardio vascular diseases traumatic infective neoplastic spine Patient having any anorectal pathology Pregnant women

Design outcomes

Primary

Measure	Time frame
To study the effect of Vaitaran Basti on Elevated CRP in Amavata patients w. s. r. to RA CRP test taken as an objective criteria for study and will be assessed after 7 days of treatmentTimepoint: 14 days	—

Secondary

Measure	Time frame
For future study in elevated C Reactive Protein in Chronic hypertensive diabetic and carcinoma patientsTimepoint: 14 days	—

Countries

India

Contacts

Public ContactVd Satish Digambar Urhe

Siddhakala Ayurveda Mahavidyalaya

drsatishurhe9@gmail.com9890035901

Outcome results